Klotho Neurosciences (KLTO) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

KLTO Klotho Neurosciences

Watchlist

0.470
+0.046+10.85%

Close Dec 24 13:00 ET

0.464
-0.006-1.19%

Post 17:01 ET

10.93MMarket Cap-1.88P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Press Release: Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences' Scientific Advisory Board
Dow JonesDec 9 11:00 ET
Press Release: Former Merck USA President Joins Klotho Neurosciences' Board of Directors
Dow JonesDec 3 11:00 ET
10-Q: Quarterly report
SECNov 19 17:06 ET · Announcements
Klotho Neurosciences Ends Licensing Agreement With Teleost
TipRanksNov 13 06:33 ET
Express News | Klotho Neurosciences - Co, Teleost Biopharmaceuticals LLC Mutually Agreed to Terminate Licensing Agreement Dated Jan 28, 2023
ReutersNov 13 06:17 ET
Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor
GlobeNewswireOct 23 06:00 ET

Comments

Stock_Drift

17 hours ago

Giant Brain.

$Klotho Neurosciences (KLTO.US)$

Stock_Drift

Dec 3 12:56

$Klotho Neurosciences (KLTO.US)$

Jaguar8

Dec 3 12:55

NEWS TODAY

$Klotho Neurosciences (KLTO.US)$
Former Merck USA President Joins Klotho Neurosciences' Board of Directors
Tuesday, 3rd December at 11:00 am
NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biotechnology company pioneering cell and gene therapies for neurodegenerative and age-related disorders, including ALS, Alzheimer's, and Parkinson's, today announced the appointment of Riad El-Dada, former US President of Merck, to its Board of Dire...

YawningKitty_x_x

Nov 29 10:06

Columns Top 5 Movers of the Day – $BGM Rises Over 30% on Acquisition News

As of November 29, U.S. markets are showing modest gains. The Dow Jones is up 0.4%, the S&P 500 is also slightly higher, and the Nasdaq is leading with nearly a 1% increase. Market sentiment remains positive, driven by favorable economic data in recent weeks. While there’s no major economic data release today, investors are focused on the Fed’s monetary policy outlook and corporate earnings, both of which continue to provide suppor...